Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 7.884 Q1 | 254 | 19 | 57 | 8938 | 935 | 57 | 15.39 | 470.42 | |
2 | Pharmacology and Toxicology, Supplement | journal | 0.138 Q3 | 7 | 1 | 40 | 389 | 16 | 40 | 0.40 | 389.00 | |
3 | Critical Reviews in Toxicology | journal | 2.039 Q1 | 129 | 13 | 53 | 2887 | 295 | 52 | 4.58 | 222.08 | |
4 | Alkaloids: Chemical and Biological Perspectives | book series | 0.772 Q2 | 15 | 11 | 22 | 2316 | 26 | 10 | 0.78 | 210.55 | |
5 | Progress in Medicinal Chemistry | journal | 0.657 Q1 | 38 | 7 | 20 | 1411 | 37 | 12 | 1.25 | 201.57 | |
6 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.271 Q1 | 70 | 31 | 22 | 5954 | 143 | 22 | 8.20 | 192.06 | |
7 | Advances in Pharmacology | journal | 1.389 Q1 | 86 | 17 | 378 | 3069 | 985 | 368 | 2.04 | 180.53 | |
8 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.380 Q1 | 82 | 12 | 30 | 1994 | 157 | 30 | 5.42 | 166.17 | |
9 | Natural Product Reports | journal | 2.402 Q1 | 211 | 42 | 96 | 6961 | 435 | 96 | 4.50 | 165.74 | |
10 | Progress in Drug Research | book series | 0.725 Q1 | 46 | 11 | 45 | 1760 | 81 | 43 | 2.03 | 160.00 | |
11 | Pharmacology and Therapeutics | journal | 2.964 Q1 | 233 | 73 | 148 | 11003 | 1043 | 148 | 7.68 | 150.73 | |
12 | Reviews in Toxicology | journal | 0.404 Q3 | 21 | 8 | 58 | 1071 | 51 | 57 | 0.88 | 133.88 | |
13 | Neurotoxicity Research | journal | 84 | 1 | 0 | 116 | 0 | 0 | 0.00 | 116.00 | ||
14 | Current Medicinal Chemistry | journal | 0.851 Q1 | 202 | 69 | 71 | 7616 | 176 | 71 | 3.15 | 110.38 | |
15 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 14 | 28 | 1509 | 2 | 28 | 0.00 | 107.79 | ||
16 | Pharmaceutical Biotechnology | journal | 0.329 Q2 | 28 | 17 | 71 | 1820 | 61 | 71 | 0.84 | 107.06 | |
17 | Expert Opinion on Therapeutic Targets | journal | 0.123 Q4 | 106 | 40 | 118 | 4160 | 9 | 116 | 0.08 | 104.00 | |
18 | Current Pharmaceutical Design | journal | 1.286 Q1 | 183 | 70 | 104 | 6965 | 293 | 102 | 2.37 | 99.50 | |
19 | Cellular and Molecular Life Sciences | journal | 1.724 Q1 | 261 | 227 | 449 | 21816 | 1104 | 447 | 2.92 | 96.11 | |
20 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 10 | 182 | 0 | 10 | 0.00 | 91.00 | ||
21 | Advanced Drug Delivery Reviews | journal | 0.978 Q1 | 366 | 102 | 348 | 9151 | 868 | 326 | 2.15 | 89.72 | |
22 | Food and Drug Law Journal | journal | 0.306 Q2 | 23 | 48 | 155 | 4007 | 59 | 155 | 0.45 | 83.48 | |
23 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.126 Q3 | 29 | 11 | 28 | 879 | 5 | 26 | 0.15 | 79.91 | |
24 | Medicinal Research Reviews | journal | 1.562 Q1 | 150 | 34 | 61 | 2700 | 243 | 61 | 2.68 | 79.41 | |
25 | Expert Opinion on Investigational Drugs | journal | 0.348 Q2 | 117 | 155 | 426 | 12075 | 435 | 418 | 1.06 | 77.90 | |
26 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.100 Q4 | 5 | 8 | 44 | 607 | 0 | 44 | 0.00 | 75.88 | |
27 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 0.608 Q2 | 99 | 12 | 14 | 900 | 30 | 14 | 2.14 | 75.00 | |
28 | Advances in Antiviral Drug Design | book series | 1.023 Q1 | 12 | 7 | 7 | 519 | 23 | 5 | 0.00 | 74.14 | |
29 | Clinical Pharmacokinetics | journal | 1.586 Q1 | 184 | 81 | 186 | 5697 | 1014 | 178 | 5.21 | 70.33 | |
30 | Drug Safety | journal | 0.795 Q1 | 140 | 92 | 208 | 6358 | 598 | 202 | 2.83 | 69.11 | |
31 | Expert Opinion on Emerging Drugs | journal | 0.264 Q3 | 54 | 20 | 43 | 1380 | 34 | 42 | 0.79 | 69.00 | |
32 | BioDrugs | journal | 0.226 Q3 | 79 | 79 | 272 | 5247 | 182 | 257 | 0.65 | 66.42 | |
33 | Investigational New Drugs | journal | 0.720 Q1 | 97 | 38 | 143 | 2490 | 301 | 142 | 2.01 | 65.53 | |
34 | Drug Resistance Updates | journal | 0.642 Q2 | 132 | 51 | 56 | 3305 | 109 | 48 | 1.95 | 64.80 | |
35 | Drug Metabolism Reviews | journal | 0.855 Q1 | 108 | 45 | 99 | 2883 | 265 | 99 | 3.29 | 64.07 | |
36 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.141 Q3 | 5 | 23 | 48 | 1457 | 4 | 46 | 0.11 | 63.35 | |
37 | Toxicology and Industrial Health | journal | 0.376 Q3 | 69 | 73 | 158 | 4477 | 177 | 157 | 1.20 | 61.33 | |
38 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.197 Q3 | 25 | 15 | 51 | 919 | 35 | 40 | 0.79 | 61.27 | |
39 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 51 | 102 | 3092 | 2 | 102 | 0.02 | 60.63 | |
40 | Revista de Ciencias Farmaceuticas Basica e Aplicada | journal | 0.103 Q4 | 20 | 14 | 12 | 826 | 1 | 12 | 0.11 | 59.00 | |
41 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.236 Q3 | 50 | 142 | 45 | 8141 | 25 | 45 | 1.17 | 57.33 | |
42 | Current Opinion in Molecular Therapeutics | journal | 67 | 93 | 0 | 5163 | 0 | 0 | 0.00 | 55.52 | ||
43 | Expert Opinion on Pharmacotherapy | journal | 93 | 16 | 0 | 861 | 0 | 0 | 0.00 | 53.81 | ||
44 | Annual Report of Shionogi Research Laboratory | journal | 0.142 Q3 | 2 | 2 | 7 | 106 | 1 | 7 | 0.25 | 53.00 | |
45 | Drugs of Today | journal | 0.203 Q3 | 57 | 102 | 273 | 5395 | 128 | 272 | 0.40 | 52.89 | |
46 | Toxin Reviews | journal | 0.205 Q4 | 54 | 24 | 93 | 1269 | 57 | 88 | 0.60 | 52.88 | |
47 | Cytokines, Cellular and Molecular Therapy | journal | 0.670 Q1 | 28 | 26 | 56 | 1337 | 101 | 55 | 1.80 | 51.42 | |
48 | Apoptosis : an international journal on programmed cell death | journal | 0.700 Q1 | 128 | 48 | 130 | 2463 | 202 | 130 | 1.44 | 51.31 | |
49 | Antiviral Chemistry and Chemotherapy | journal | 0.497 Q2 | 59 | 32 | 176 | 1616 | 306 | 175 | 1.79 | 50.50 | |
50 | Mutation Research - DNA Repair | journal | 2.292 Q1 | 75 | 64 | 210 | 3172 | 656 | 210 | 3.01 | 49.56 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®